[The clinical value of 3 alpha-androstanediol-glucuronide in hirsute women].
Aim of this prospective diagnostic study was to determine the serum 3 alpha-androstanediol-glucuronide (AdiolG) level in hirsute women in order to assess the androgenic activity in peripheral tissue and to differentiate between hirsutism of peripheral origin and that of adrenal or ovarian origin. Diagnostic advantages might have been expected in patients with idiopathic hirsutism, in whom increased 5 alpha-reductase activity may be reflected by this parameter. Apart from serum AdiolG, we determined the established parameters testosterone, androstendione and dehydroepiandosterone sulfate in 63 hirsute premenopausal women and in 51 non-hirsute controls. AdiolG (P < 0.05), as well as the 3 established parameters (P < 0.001) were elevated in the hirsute women as compared with the controls; however, the subgroup of women with idiopathic hirsutism (n = 32) showed no elevation of serum AdiolG. Analysis of the combined hirsute and control groups showed that the correlation of AdiolG to the hirsutism score (r = 0.42) was markedly weaker than that of testosterone to the latter (r = 0.62). Moreover, no correlation was found between the body-mass index and AdiolG. Our data show that serum AdiolG is obviously not a specific marker for peripheral 5 alpha-reductase activity, but appears to reflect the adrenal and ovarian androgen precursors. Thus, determination of serum AdiolG is of no diagnostic benefit in the clinical assessment of hirsute women.
Joura
E A
EA
Universitätsklinik für Frauenheilkunde, Allgemeines Krankenhaus Wien, Osterreich.
Sator
M O
MO
Geusau
A
A
Zeisler
H
H
Söregi
G
G
Huber
J C
JC
D000293:Adolescent; D000328:Adult; D000728:Androgens / Q000097:blood; D015113:Androstane-3,17-diol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood; D015992:Body Mass Index; D003937:Diagnosis, Differential; D005260:Female; D006628:Hirsutism / Q000175:diagnosis / Q000209:etiology*; D006801:Humans; D011446:Prospective Studies; D016896:Treatment Outcome
D000728:Androgens; D015113:Androstane-3,17-diol; C028895:androstane-3,17-diol glucuronide
Die klinische Wertigkeit von 3 alpha-Androstanediol-Glucuronid bei hirsuten Frauen.